Standard MRI: searching for clues
Differentiating tumefactive demyelination from malignant glioma based solely on standard magnetic resonance imaging protocols can be extremely difficult. Nevertheless, there are a number of reliable imaging patterns that should alert the diagnostician to a demyelinating process.
First, pay attention to the mass effect (mass effect) and vasogenic edema. In demyelination, these are relatively mild despite the impressive size of the lesion itself.
Second, look for the "open-ring" sign. This is the most striking feature on gadolinium-enhanced T1-weighted images. Contrast enhancement at the periphery of the lesion is incomplete, forming a broken ring or horseshoe. Crucially, the open edge of this ring always faces the cortical or subcortical gray matter.
Third, on T2-WI, one can sometimes notice a thin rim of peripheral hypointensity, which is also atypical for most gliomas.
MR spectroscopy (1H-MRS): analyzing metabolites
When standard MRI is insufficient to reliably rule out a high-grade glioma (high-grade glioma), advanced techniques come into play. Proton MR spectroscopy reveals the chemical composition of the lesion.
The baseline pattern of tumefactive demyelination includes the appearance of lactate, macromolecules, and lipids, as well as choline-containing compounds (Cho) against the background of a sharp decrease in N-acetylaspartate (NAA) levels. The catch is that this profile is virtually identical to that of a high-grade glioma.
The differential diagnosis is based on subtle differences:
- Signs of demyelination: elevated levels of glutamine and glutamate.
- Signs of a tumor: a pronounced increase in myo-inositol (myo-inositol) and a significant choline (Cho) peak.
MR perfusion (DSC MR perfusion): assessing blood flow
Dynamic susceptibility contrast (DSC) MR perfusion allows resolving ambiguities by analyzing the relative cerebral blood volume (rCBV). The differences here are dictated by tissue biology itself.
Grade IV gliomas (Grade IV gliomas) are characterized by active neoangiogenesis and rapid endothelial proliferation. The tumor vascular network proliferates pathologically, which results in a marked increase in rCBV on perfusion maps.
In tumefactive demyelination, vessels remain normal or show only inflammatory angiogenesis. Therefore, the rCBV value remains normal or slightly elevated, allowing malignant growth to be confidently ruled out.
Imaging examples
Let us examine typical tomographic manifestations:
- Acute Baló's concentric sclerosis-like lesion (Baló-like lesion). Alternating concentric bands are clearly visible on the scans. T1-WI shows peripheral contrast enhancement, while the apparent diffusion coefficient map (ADC map) demonstrates restricted diffusion at the periphery of the lesion.
- Typical tumefactive inflammatory lesion. A large periventricular lesion is observed (often with vasogenic edema on T2-FLAIR). Contrast-enhanced T1-WI reveals the aforementioned open ring facing the medial cortex. The color CBV map demonstrates only a minimal increase in perfusion compared to unaffected white matter.
Briefly: answers to topical questions
What threshold lesion size in centimeters is used to classify a lesion as tumefactive?
The threshold lesion size for classifying a lesion as tumefactive is greater than 2 centimeters. On MRI, such lesions typically appear as large, solitary, or multiple well-defined lesions in the cerebral hemispheres (supratentorial white matter), but may involve the gray matter and spinal cord. They are characterized by minimal mass effect or edema, and due to their hypercellular structure, can clinically and radiologically mimic tumors.
With which intracranial mass lesions is the differential diagnosis of tumefactive demyelination performed?
The differential diagnosis of tumefactive demyelination is performed with malignant gliomas, specifically high-grade gliomas (high-grade gliomas). Due to their hypercellular structure, these lesions can clinically and radiologically mimic a brain tumor. Distinguishing them based solely on standard MRI may be impossible, which is why advanced techniques such as proton MR spectroscopy and dynamic MR perfusion are used. Unlike Grade IV gliomas, which are characterized by neoangiogenesis, demyelination features normal or inflamed vessels.
What types of contrast enhancement patterns are encountered in tumefactive demyelinating lesions?
Tumefactive demyelinating lesions exhibit the following types of contrast enhancement patterns:
- The "open-ring" sign — incomplete annular contrast enhancement where the open margin always faces the cortical or subcortical gray matter.
- Peripheral enhancement — contrast enhancement along the periphery of the lesion (e.g., in acute Baló's concentric sclerosis-like lesions).
- Ring-like enhancement (ring-like enhancement) — closed contrast enhancement along the contour of the lesion.
How does tumefactive demyelination differ from a bacterial brain abscess on DWI and ADC maps?
The main difference lies in the location of the restricted diffusion zone.
| Sign | Tumefactive demyelination | Bacterial abscess |
|---|---|---|
| DWI | Peripheral restricted diffusion (restricted diffusion) | High signal in the center (cavity) of the abscess |
| ADC maps | Decreased diffusion at the periphery of the lesion | Low values in the center due to viscous pus |
Remember the letter "C" rule for MRI: contrast in demyelination accumulates in the shape of a C (open ring), and its open part always "Faces the Cortex" (C looks at Gray matter).
Class and exam questions
Why are tumefactive lesions confused with gliomas?
Due to their hypercellular structure, they form large lesions in the hemispheres that mimic a mass lesion (tumor) on basic MRI sequences.
What does MR perfusion show in demyelination?
Unlike malignant gliomas with active neoangiogenesis, relative cerebral blood volume (rCBV) remains normal or only slightly elevated in demyelination.
What are the limitations of MR spectroscopy in this pathology?
The baseline spectral pattern (presence of lactate, lipids, reduced NAA) is nearly identical to that of high-grade glioma. They can be distinguished only by specific metabolites (glutamine/glutamate vs. myo-inositol).
What else to study on this topic
- Pathogenesis and causes of tumefactive lesion formation
- The relationship between tumefactive lesions and multiple sclerosis
- Features of Baló's concentric sclerosis imaging findings
- Physical principles of proton MR spectroscopy (1H-MRS)
- Histological appearance of hypercellular demyelinating lesions
Master the entire topic in the "Diagnostic Radiology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Pseudotumoral Demyelinating Lesions" and another 2,199 pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 10 video lessons on the subject
Other topics in the Neuroimaging section
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.